NeuroMetrix, Inc.
NASDAQ: NURO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Shai N. Gozani
- Employees
- 13
- Headquarters
- Woburn, United States
- IPO year
- 2004
- Market cap
- $9.4M
- Website
- https://www.neurometrix.com
Loading NURO…
Loading profile data…Frequently asked questions about NURO
What does NeuroMetrix, Inc. (NURO) do?
NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. T...
Where does NURO trade?
NeuroMetrix, Inc. (NURO) trades on the NASDAQ Capital Market.
What sector is NURO in?
NeuroMetrix, Inc. (NURO) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of NeuroMetrix, Inc.?
Shai N. Gozani is the chief executive officer of NeuroMetrix, Inc. (NURO).
Where is NeuroMetrix, Inc. headquartered?
NeuroMetrix, Inc. is headquartered in United States.
Does NURO pay a dividend?
NeuroMetrix, Inc. (NURO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NURO go public?
NeuroMetrix, Inc. (NURO) completed its initial public offering in 2004.